Header Logo

Connection

Nirav Shah to Antigens, CD20

Back to Details
This is a "connection" page, showing publications Nirav Shah has written about Antigens, CD20.
Nirav Shah
Connection Strength
0.688
Antigens, CD20
  1. Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial. Nat Med. 2020 10; 26(10):1569-1575.
    View in: PubMed
    Score: 0.688
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.